Discovery Platform
A Powerful Tech Stack for Validating Difficult Targets
Join our panel, October 16th, 1:50 PM ET
Epitope-Steering and Antibody Optimization
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
Collaborating to develop first-in-class and best-in-class molecules for obesity, diabetes, and heart disease
Advancing our preclinical pipeline and innovating with our partners to overcome oncology’s discovery and development challenges
License our discovery platform or collaborate with us to advance our high-value pipeline assets
From precision antibody identification and optimization to tailored bispecifics and a cutting-edge masking technology
An antibody masking technology for delivering on-epitope, on-tissue clinical candidates with enhanced safety and developability
a CD3-BASED T-CELL ENGAGER Platform
Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline
Meet the team driving iBio’s powerful tech stack for drug discovery
For Investor inquiries, please visit our Investor Site